Different genospecies of borrelia burgdorferi are associated with distinct clinical manifestations of lyme borreliosis

Clinical Infectious Diseases

Volumn 17, Issue 4, 1993, Pages 708-717

  Van Dam, Alje P ^a,b   Kuiper, Herman ^a,b,c   Vos, Koen ^a,b,d   Widjojokusumo, Anneke ^a,b   De Jongh, Bartelt M ^a,b,e   Spanjaard, Lodewijk ^a,b   Ramselaar, Anton C P ^a,b,c   Kramer, Michael D ^a,b   Dankert, Jacob ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Department of Neurology ^*  (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRALGIA; ARTHRITIS; ARTICLE; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CARDITIS; CEREBROSPINAL FLUID CULTURE; ERYTHEMA CHRONICUM MIGRANS; GEOGRAPHIC DISTRIBUTION; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MYALGIA; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; STRAIN DIFFERENCE; TICK;

ACRODERMATITIS; ANIMAL; ARACHNID VECTORS; ARTHRITIS, INFECTIOUS; BLOTTING, WESTERN; BORRELIA BURGDORFERI GROUP; CEREBROSPINAL FLUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHEMA CHRONICUM MIGRANS; GENOTYPE; HUMAN; LYME DISEASE; NERVOUS SYSTEM DISEASES; NETHERLANDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL; SKIN; TICKS;

EID: 0027358358     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/17.4.708     Document Type: Article

References (26)

1. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96.
2. Asbrink E, Brehmer-Andersson E, Hovmark A. Acrodermatitis chronica atrophicans: a spirochetosis. Clinical and histological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius. Am J Dermatopathol 1986;8:209-19.
3. Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992;42:378-83
4. Adam T, Gassmann GS, Rasiah C, GObel UB. Phenotypic and genotypic analysis of Borrelia burgdorferi isolates from various sources. Infect Immun 1991;59:2579-85.
5. Wilske B, Preac-Mursic V, GObel UB, et al. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 1993;31:340-50.
6. Boerlin P, Peter O, Bretz AG, Postic D, Baranton G, Piffaretti JC. Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun 1992;60:1677-83.
7. Welsh J, Pretzman C, Postic D, Saint Girons I, Baranton G, McClelland M. Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int J Syst Bacteriol 1992;42:370-7.
8. Marconi RT, Garon CF. Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 1992;30:2830-4.
9. Picken RN. Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol 1992;30:99-114.
10. Wallich R, Helmes C, Schaible UF, et al. Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. Infect Immun 1992;60:4856-66.
11. Centers for Disease Control. Case definition for public health surveillance. MMWR 1990,39(RR-13):19-21.
12. Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zentralbl Bakteriol A 1986;263:112-8.
13. Peter O, Bretz AG. Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification. Int J Med Microbiol Virol Parasitol Infect Dis 1992;277:28-33.
14. Barbour AG, Heiland RA, Howe TR. Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis 1985;152:478-84.
15. Kramer MD, Schaible UE, Wallich R, Moter SE, Petzoldt D, Simon MM. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies. Immunobiology 1990;181:357-66.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Morrissey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981;117:307-10.
18. Wilson K. Preparation of genomic DNA from bacteria. In: Ausbel FM, Brent R. Kingston RE, et al., eds. Current protocols in molecular biology. Vol 1. Brooklyn, New York: John Wiley & Sons, 1988;241-245.
19. Sambrook J., Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
20. Grimont F, Grimont PAD. Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools. Ann Inst Pasteur Microbiol 1986;137B:165-75.
21. Berger BW, Johnson RC, Kodner C, Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992;30:359-61.
22. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990;28:473-9.
23. Asbrink E, Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients: a comparison with Lyme disease. Acta Derm Venereol (Stockh) 1985;65:43-52.
24. Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM, Weinberger K. Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 1989;39:1118-20.
25. bArsink E. Cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis Suppl 1991;77:44-50.
26. Kaufman LD, Gruber BL, Phillips ME, Benach JL. Late cutaneous Lyme disease: acrodermatitis chronica atrophicans. Am J Med 1989;86:828-30.